Recurrent pterygium resection associated to fibrin membrane graft: report of two cases

Detalhes bibliográficos
Autor(a) principal: Giralt,Isabel Mogollón
Data de Publicação: 2021
Outros Autores: Bueis,Ana Boto de los, Zarzuelo,Almudena del Hierro, Moreno,José Vicente Dabad, Milner,Rafael Montejano, Corcuera,Borja de la Sen
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Revista Brasileira de Oftalmologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802021000200146
Resumo: ABSTRACT We propose a novel surgical technique in cases of aggressive recurrent pterygium non-subsidiary of treatment with conjunctival autografts or antimetabolites. Two presented cases were treated with surgical excision and a sutured plasma rich in growth factors membrane (mPRGF) followed by rich in growth factors (PRGF) eye drops treatment. After surgery, dexamethasone, tobramycin and PRGF eye drops were prescribed for 6 weeks. After a 12-month and 3-year post-surgical follow-up respectively, treated eyes with mPRGF did not present relapse, and visual acuity improved in both cases. No ocular complications, pain, eye discomfort nor other symptoms were observed. The combined use of PRGF eye drops and mPRGF seems an effective and safe therapy for recurrent pterygium.
id SBO-1_69d4db812e53169acde0c94bfdfab13a
oai_identifier_str oai:scielo:S0034-72802021000200146
network_acronym_str SBO-1
network_name_str Revista Brasileira de Oftalmologia (Online)
repository_id_str
spelling Recurrent pterygium resection associated to fibrin membrane graft: report of two casesPterygiumRecurrencePlatelet-rich fibrinPlatelet-rich plasmaOphthalmic solutionsTissue engineeringABSTRACT We propose a novel surgical technique in cases of aggressive recurrent pterygium non-subsidiary of treatment with conjunctival autografts or antimetabolites. Two presented cases were treated with surgical excision and a sutured plasma rich in growth factors membrane (mPRGF) followed by rich in growth factors (PRGF) eye drops treatment. After surgery, dexamethasone, tobramycin and PRGF eye drops were prescribed for 6 weeks. After a 12-month and 3-year post-surgical follow-up respectively, treated eyes with mPRGF did not present relapse, and visual acuity improved in both cases. No ocular complications, pain, eye discomfort nor other symptoms were observed. The combined use of PRGF eye drops and mPRGF seems an effective and safe therapy for recurrent pterygium.Sociedade Brasileira de Oftalmologia2021-04-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802021000200146Revista Brasileira de Oftalmologia v.80 n.2 2021reponame:Revista Brasileira de Oftalmologia (Online)instname:Sociedade Brasileira de Oftalmologia (SBO)instacron:SBO10.5935/0034-7280.20210028info:eu-repo/semantics/openAccessGiralt,Isabel MogollónBueis,Ana Boto de losZarzuelo,Almudena del HierroMoreno,José Vicente DabadMilner,Rafael MontejanoCorcuera,Borja de la Seneng2021-09-01T00:00:00Zoai:scielo:S0034-72802021000200146Revistahttps://rbo.emnuvens.com.br/rbo/indexhttps://old.scielo.br/oai/scielo-oai.phpsob@sboportal.org.br||rbo@sboportal.org.br1982-85510034-7280opendoar:2021-09-01T00:00Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)false
dc.title.none.fl_str_mv Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
title Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
spellingShingle Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
Giralt,Isabel Mogollón
Pterygium
Recurrence
Platelet-rich fibrin
Platelet-rich plasma
Ophthalmic solutions
Tissue engineering
title_short Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
title_full Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
title_fullStr Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
title_full_unstemmed Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
title_sort Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
author Giralt,Isabel Mogollón
author_facet Giralt,Isabel Mogollón
Bueis,Ana Boto de los
Zarzuelo,Almudena del Hierro
Moreno,José Vicente Dabad
Milner,Rafael Montejano
Corcuera,Borja de la Sen
author_role author
author2 Bueis,Ana Boto de los
Zarzuelo,Almudena del Hierro
Moreno,José Vicente Dabad
Milner,Rafael Montejano
Corcuera,Borja de la Sen
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Giralt,Isabel Mogollón
Bueis,Ana Boto de los
Zarzuelo,Almudena del Hierro
Moreno,José Vicente Dabad
Milner,Rafael Montejano
Corcuera,Borja de la Sen
dc.subject.por.fl_str_mv Pterygium
Recurrence
Platelet-rich fibrin
Platelet-rich plasma
Ophthalmic solutions
Tissue engineering
topic Pterygium
Recurrence
Platelet-rich fibrin
Platelet-rich plasma
Ophthalmic solutions
Tissue engineering
description ABSTRACT We propose a novel surgical technique in cases of aggressive recurrent pterygium non-subsidiary of treatment with conjunctival autografts or antimetabolites. Two presented cases were treated with surgical excision and a sutured plasma rich in growth factors membrane (mPRGF) followed by rich in growth factors (PRGF) eye drops treatment. After surgery, dexamethasone, tobramycin and PRGF eye drops were prescribed for 6 weeks. After a 12-month and 3-year post-surgical follow-up respectively, treated eyes with mPRGF did not present relapse, and visual acuity improved in both cases. No ocular complications, pain, eye discomfort nor other symptoms were observed. The combined use of PRGF eye drops and mPRGF seems an effective and safe therapy for recurrent pterygium.
publishDate 2021
dc.date.none.fl_str_mv 2021-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802021000200146
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802021000200146
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/0034-7280.20210028
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Oftalmologia
publisher.none.fl_str_mv Sociedade Brasileira de Oftalmologia
dc.source.none.fl_str_mv Revista Brasileira de Oftalmologia v.80 n.2 2021
reponame:Revista Brasileira de Oftalmologia (Online)
instname:Sociedade Brasileira de Oftalmologia (SBO)
instacron:SBO
instname_str Sociedade Brasileira de Oftalmologia (SBO)
instacron_str SBO
institution SBO
reponame_str Revista Brasileira de Oftalmologia (Online)
collection Revista Brasileira de Oftalmologia (Online)
repository.name.fl_str_mv Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)
repository.mail.fl_str_mv sob@sboportal.org.br||rbo@sboportal.org.br
_version_ 1752122339200335872

Registros relacionados